BALTIMORE, January 18, 2022 /PRNewswire/ — InVita Healthcare Technologies, a leading software provider for complex medical, forensic and community care environments, announces its investment in Transplant Connect, the world’s leading software provider for the donation and of transplantation.
The software managing the donation and transplantation of organs, tissues, eyes and birth tissues is a natural complement for InVita.
“We are really excited about this investment from InVita,” said John Piano, Founder, President and CEO, Transplant Connect. “Through this investment, we will be able to expand our vital resources and capabilities and significantly scale our innovation, allowing us to better connect the donation and transplantation ecosystem and help save and to heal more lives in the United States and around the world. Our combined resources will allow us to leverage the unprecedented success of Transplant Connect for over 17 years and take our offerings to the next level. »
This strategic investment will help accelerate the continued expansion of Transplant Connect iTransplantation℠ platform and iReferral℠ automated donor referral technology. the iTransplant℠ the platform supports nearly 75% of all deceased organ, tissue and eye donations in United States and is used by over 12,500 healthcare professionals in over 100 organ, tissue, eye and birth tissue organizations worldwide.
“We welcome Transplant Connect and its world-class products to InVita’s strong portfolio serving complex medical environments,” said Todd Collins, President and CEO of InVita. “Software that manages critical operations, such as organ, tissue, eye and birth tissue donation and transplantation, is a natural fit for InVita. This investment reinforces our mission to provide the most innovative and comprehensive solutions for managing complex medical workflows. We are proud to work with the leader in this field.”
About InVita Healthcare Technologies | invitahealth.com
InVita provides chain-of-custody software technologies for complex medical, forensic and community care environments. InVita’s solutions optimize supply chains, sample tracking, and visibility into blood and plasma operations, tissue and implant lifecycles, and environments spanning DNA and forensics. InVita’s solutions help increase compliance and cost control, reduce risk and improve patient and public safety outcomes.
About Transplant Connect | transplantconnect.com
Founded in 2004 as a mission-driven medical software company, Transplant Connect is the world’s leading provider of human biological donation and transplantation software (organs, tissues, eyes, placenta and more). Included in the company’s growing suite of solutions are iTransplantation℠, a secure cloud platform for clinical management, communications, analytics and logistics, and iReferral℠, the first and only automated donor referral technology available to hospitals, medical examiners/coroners, organ procurement agencies, tissue banks and eye banks.
Show original content to download multimedia:https://www.prnewswire.com/news-releases/invita-healthcare-technologies-invests-in-transplant-connect-to-expand-software-solutions-for-human-biologics-301462321.html
SOURCE InVita Healthcare Technologies